ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Synchrony Financial

Synchrony Financial (SFE)

62,90
0,00
(0,00%)
Geschlossen 26 Dezember 10:00PM
Echtzeitdaten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
62,90
Gebot
62,90
Fragen
62,90
Volumen
0,00
0,00 Tagesbereich 0,00
32,44 52-Wochen-Bereich 65,99
Marktkapitalisierung
Handelsende
62,90
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
440
Ausgegebene Aktien
389.344.383
Dividendenrendite
1.66%
Kurs-Gewinn-Verhältnis
11,84
Gewinn pro Aktie (EPS)
5,64
Erlöse
13,63B
Nettogewinn
2,2B

Über Synchrony Financial

Sektor
Finance Services
Branche
Finance Services
Hauptsitz
Stamford, Connecticut, USA
Gegründet
-
Synchrony Financial is listed in the Finance Services sector of the Tradegate (DE) with ticker SFE. The last closing price for Synchrony Financial was 62,90 €. Over the last year, Synchrony Financial shares have traded in a share price range of 32,44 € to 65,99 €.

Synchrony Financial currently has 389.344.383 shares in issue. The market capitalisation of Synchrony Financial is 24,49 € billion. Synchrony Financial has a price to earnings ratio (PE ratio) of 11.84.

SFE Neueste Nachrichten

MDB Capital Group Announces 'Best and Brightest' List of Qualifying Companies for 1st Annual Bright Lights Conference in San Fra

Bright Lights Conference Will Showcase 50 of the Most Innovative U.S. Small Cap Companies with Disruptive Intellectual Property in San Francisco on May 10 - 12, 2010 SANTA MONICA, Calif., Feb. 17...

Molecular Biometrics Closes $12.5 Million Series B Equity Funding

NORWOOD, Mass., Jan. 12 /PRNewswire/ -- Molecular Biometrics®, Inc., a metabolomics company developing novel clinical diagnostic tools for applications in personalized medicine, today announced...

Clarient Reports 41% Revenue Increase for First Quarter 2009

New Molecular Tests and Increased Case Volume Continue to Drive Revenue Growth ALISO VIEJO, Calif., May 6 /PRNewswire-FirstCall/ -- Clarient, Inc. (NASDAQ:CLRT), a premier anatomic pathology and...

Clarient Launches New Breast Cancer Test

The Clarient Insight(R) Dx Breast Cancer Profile Assists Physicians In Identifying Recurrence Risk and the Need for Chemotherapy ALISO VIEJO, Calif., May 5 /PRNewswire-FirstCall/ -- Clarient...

Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corpor

FOXA1 biomarker predicts likelihood of recurrence and long-term disease-free survival of breast cancer patients; Further strengthens Company's breast cancer menu ALISO VIEJO, Calif., April 23...

Clarient to Present at the Cowen and Company 29th Annual Health Care Conference on Tuesday, March 17th

Presentation Scheduled for 8:45am EDT ALISO VIEJO, Calif., March 12 /PRNewswire-FirstCall/ -- Clarient, Inc. (NASDAQ:CLRT), a premier technology and services resource for pathologists...

Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008

New Molecular Tests and Increasing Case Volumes Drive 78 Percent Revenue Growth in the Fourth Quarter of 2008 as Compared to the Prior Year Period ALISO VIEJO, Calif., March 11...

Laureate Pharma Appoints Gary Swan as Vice President of Operations

- Augments Senior Management Team with more than 30 Years Experience in Biopharmaceutical Manufacturing, Engineering, Technical Services and Validation - PRINCETON, N.J., Feb. 14 /PRNewswire/...

Laureate Pharma Extends Lease for its Facility in Princeton, NJ

Amendment extends lease through 2016 with options through 2026 PRINCETON, N.J., April 25 /PRNewswire/ -- Laureate Pharma, Inc., a full- service biopharmaceutical development and protein...

EDGAR(R) Online, Inc. Announces Appointment of Philip Moyer as President

Former Microsoft Executive to Assume Key Management Position NORWALK, Conn., April 10 /PRNewswire-FirstCall/ -- EDGAR(R) Online, Inc. (NASDAQ:EDGR) announced today that Philip Moyer will assume...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-2.4-3.6753445635565.365.98999961.4446062.55562364DE
4-0.73-1.147257582963.6365.98999961.4459963.72466934DE
1218.67542.227247032244.22565.98999943.8744060.01493257DE
2621.16550.712830957241.73565.98999938.8244351.76744472DE
5228.482.318840579734.565.98999932.4444645.41685639DE
15622.0553.977968176340.8565.98999924.1628138.81761999DE
26030.05591.505556401332.84565.98999911.71424937.66837322DE

SFE - Frequently Asked Questions (FAQ)

What is the current Synchrony Financial share price?
The current share price of Synchrony Financial is 62,90 €
How many Synchrony Financial shares are in issue?
Synchrony Financial has 389.344.383 shares in issue
What is the market cap of Synchrony Financial?
The market capitalisation of Synchrony Financial is EUR 24,49B
What is the 1 year trading range for Synchrony Financial share price?
Synchrony Financial has traded in the range of 32,44 € to 65,99 € during the past year
What is the PE ratio of Synchrony Financial?
The price to earnings ratio of Synchrony Financial is 11,84
What is the cash to sales ratio of Synchrony Financial?
The cash to sales ratio of Synchrony Financial is 1,91
What is the reporting currency for Synchrony Financial?
Synchrony Financial reports financial results in USD
What is the latest annual turnover for Synchrony Financial?
The latest annual turnover of Synchrony Financial is USD 13,63B
What is the latest annual profit for Synchrony Financial?
The latest annual profit of Synchrony Financial is USD 2,2B
What is the registered address of Synchrony Financial?
The registered address for Synchrony Financial is CORPORATION TRUST CENTER, 1209 ORANGE ST, STAMFORD, CONNECTICUT, 19801
What is the Synchrony Financial website address?
The website address for Synchrony Financial is www.synchrony.com
Which industry sector does Synchrony Financial operate in?
Synchrony Financial operates in the FINANCE SERVICES sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
0RARAPT Therapeutics Inc
1,61 €
(101,25%)
83,81k
KASHIntellabridge Technology Corp
0,047 €
(88,00%)
1,24M
4APApollo Minerals Ltd
0,01 €
(66,67%)
30
AWY0Percheron Therapeutics Ltd
0,007 €
(55,56%)
660k
1W81WISeKey International Holding Ltd
9,70 €
(44,78%)
4,81k
WWTWater Ways Technologies Inc
0,0045 €
(-95,91%)
2,53k
L7C2Windfall Geotek Inc
0,0025 €
(-70,59%)
40k
QP9Atco Mining Inc
0,003 €
(-55,88%)
1,5k
0PV2Moovly Media Inc
0,002 €
(-55,56%)
500
8QPFidus Investment Corp
9,5899 €
(-51,32%)
220
013CJDcom Inc
17,426 €
(0,00%)
0
013AJD.com Inc
34,90 €
(0,00%)
0
0110Thesis Gold Inc
0,391 €
(0,00%)
0
00WAspermont Ltd
0,004 €
(0,00%)
0
000Greenvolt Energias Renovaveis SA
0,00 €
(0,00%)
0
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock